Analysis of the efficacy of antiepileptic drugs in the treatment of infantile spasms and focal epilepsy associated with tuberous sclerosis complex

Cover Page

Cite item

Full Text

About the authors

A. V. Grigoryeva

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Author for correspondence.
Email: ton.grigorjewa2010@yandex.ru

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

Russian Federation

M. Yu. Dorofeeva

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: fake@neicon.ru

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

Russian Federation

V. S. Perminov

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: fake@neicon.ru

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

Russian Federation

E. D. Belousova

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: fake@neicon.ru

Department of Epileptology and Psychoneurology, Research and Clinical Institute for Pediatrics named after Yu.E Vel’tishev

2 Taldomskaya St., Moscow 125412

Russian Federation

References

  1. Belousiva E.D. Dorofeeva M.Yu., Pivovarova A.M., Katysheva O.V. Diagnosis of tuberous sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2015;115(5):46–51. (In Russ.).
  2. Curatolo P., Jóźwiak S., Nabbout R., TSC Consensus Meeting for SEGA and Epilepsy Management. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 2012;16(6):582–6. PMID: 22695035. doi: 10.1016/j.ejpn.2012.05.004.
  3. Curatolo P., Moavero R., de Vries P.J. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 2015;14(7):733–45. PMID: 26067126. doi: 10.1016/S14744422(15)00069-1.
  4. Cusmai R., Moavero R., Bombardieri R. et al. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy Behav 2011;22(4):735–9. PMID: 22142783. doi: 10.1016/j.yebeh.2011.08.037.
  5. Fallah A., Guyatt G.H., Snead O.C. et al. Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing resective epilepsy surgery: An Individual Participant Data Meta-Analysis. PLoS One 2013;8(2):e53565. PMID: 23405072. doi: 10.1371/journal.pone.0053565.
  6. Fallah A., Weil A.G., Wang S. et al. Costutility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex. Epilepsy Behav 2016;63:79–88. PMID: 27591681. doi: 10.1016/j.yebeh.2016.07.034.
  7. Epileptic spasms. Available at: https://www.epilepsydiagnosis.org/seizure/epileptic-spasms-overview.html.
  8. Jeong A., Nakagawa J.A., Wong M. Predictors of drug resistant epilepsy in tuberous sclerosis complex. J Child Neurol 2017;32(14):1092–8. PMID: 29129154. doi: 10.1177/0883073817737446.
  9. Krueger D.A., Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49(4):255–26. PMID: 24053983. doi: 10.1016/j.pediatrneurol.2013.08.002.
  10. Lux A.L., Osborne J.P. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 2004;45(11):1416–28. PMID: 15509243. doi: 10.1111/j.0013-9580.2004.02404.x.
  11. Major P., Thiele E.A. Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav 2008;13(2):357–60. PMID: 18468492. doi: 10.1016/j.yebeh.2008.04.001.
  12. Northrup H., Krueger D.A. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 2013;49(4):243–54.
  13. Overwater I.E., Bindels-de Heus K., Rietman A.B. et al. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs. Epilepsia 2015;56(8):1239–45. doi: 10.1111/epi.13050.
  14. Roach E.S., Di Mario F.J., Kandt R.S., Northrup H. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. J Child Neur 1999;14(6):401–7. doi: 10.1177/088307389901400610.
  15. Saxena A., Sampson J.R. Epilepsy in tuberous sclerosis: phenotypes, mechanisms, and treatments. Semin Neurol 2015;35(3):269–76. doi: 10.1055/s-0035-1552616.
  16. Scheffer I.E., Berkovic S., Capovilla G. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58(4):512–21. doi: 10.1111/epi.13709.
  17. Zhang B., McDaniel S.S., Rensing N.R., Wong M. Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One 2013;8(2);e57445. PMID: 23437388. doi: 10.1371/journal.pone.0057445.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 22926 от  12.01.2006.